We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 35 Manufacturers, Suppliers and Companies | IPROS GMS

Last Updated： Aggregation Period:Jun 24, 2026～Jul 21, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Jun 24, 2026～Jul 21, 2026
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. 恵命堂 Tokyo//Pharmaceuticals and Biotechnology
  3. ケーナインラボ Tokyo//Testing, Analysis and Measurement
  4. 4 null/null
  5. 5 カツマタ 医薬品製造販売部 Shizuoka//Medical and Welfare
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Jun 24, 2026～Jul 21, 2026
This ranking is based on the number of page views on our site.

  1. Useful Information: The History of Gajutsu 恵命堂
  2. K9 Lab Inc. Company Profile ケーナインラボ
  3. Sogo Pharmaceutical Co., Ltd. Company Profile 相互薬工
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.

medicine Product List

91～120 item / All 155 items

Displayed results
[Research Material] Global Market for Renal Cell Carcinoma Treatment Drugs

[Research Material] Global Market for Renal Cell Carcinoma Treatment Drugs

Global Market for Renal Cell Carcinoma Treatments: Somatostatin Analogues, Targeted Therapies, Chemotherapy, Hospitals, Clinics, Oncology Centers

This research report (Global Renal Cell Carcinoma Drugs Market) investigates and analyzes the current status and outlook for the global market of renal cell carcinoma treatment drugs over the next five years. It includes information on the overview of the global renal cell carcinoma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include somatostatin analogs, targeted therapies, and chemotherapy, while the segments by application focus on hospitals, clinics, and oncology centers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of renal cell carcinoma treatment drugs. It also includes the market share of major companies in renal cell carcinoma treatment drugs, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Subarachnoid Space Treatment Drugs

[Research Material] Global Market for Subarachnoid Space Treatment Drugs

World Market for Subarachnoid Space Treatment Drugs: Baclofen Injection, Ziconotide Intrathecal Injection, Morphine Injection, Adults, Children & Adolescents

This research report (Global Intrathecal Drug Market) investigates and analyzes the current status and outlook for the global market of subarachnoid space treatment drugs over the next five years. It includes information on the overview of the global subarachnoid space treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include baclofen injection, ziconotide intrathecal injection, and morphine injection, while the segments by application focus on adults, children, and teenagers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of subarachnoid space treatment drugs. It also includes the market share of major companies in the subarachnoid space treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hepatic Encephalopathy (HE) Treatment Drugs

[Research Material] Global Market for Hepatic Encephalopathy (HE) Treatment Drugs

Global Market for Hepatic Encephalopathy (HE) Treatments: Lactulose, Rifaximin, Neomycin, Probiotics, Thiamine, Acute Liver Failure, Liver Cirrhosis

This research report (Global Hepatic Encephalopathy (HE) Therapeutics Market) investigates and analyzes the current status and outlook for the global market of hepatic encephalopathy (HE) therapeutics over the next five years. It includes information on the global hepatic encephalopathy (HE) therapeutics market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for hepatic encephalopathy (HE) therapeutics by type include lactulose, rifaximin, neomycin, probiotics, and thiamine, while the segments by application focus on acute liver failure and cirrhosis. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for hepatic encephalopathy (HE) therapeutics. It also includes the market share of major companies in the hepatic encephalopathy (HE) therapeutics market, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Ebola Treatment

[Research Material] The Global Market for Ebola Treatment

Global Market for Ebola Treatment: Vaccines (in trials), Drugs (in trials), Hospitals, Outpatient Surgery Centers, Specialized Clinics, Army Camps (Veteran Facilities)

This research report (Global Ebola Treatment Market) investigates and analyzes the current state and outlook for the global Ebola treatment market over the next five years. It includes information on the overview of the global Ebola treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Ebola treatment market focus on vaccines (in trials) and drugs (in trials), while the segments by application target hospitals, outpatient surgery centers, specialty clinics, and military camps (veteran facilities). The regional segments calculate the market size for Ebola treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Ebola treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Myocardial Infarction Treatment Drugs

[Research Material] Global Market for Myocardial Infarction Treatment Drugs

Global Market for Myocardial Infarction Treatment Drugs: JVS-200, KR-33028, AMRS-001, ANG-4011, Balixafortide, CA ...

This research report (Global Myocardial Infarction Drug Market) investigates and analyzes the current state and outlook for the global market for myocardial infarction treatment drugs over the next five years. It includes information on the overview of the global myocardial infarction treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include JVS-200, KR-33028, AMRS-001, ANG-4011, Valiciclovir, CAP-1002, Sendelicitide, and others, while the segments by application focus on research centers, hospitals, and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for myocardial infarction treatment drugs. It also includes the market share of major companies in the myocardial infarction treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Mucopolysaccharidosis Treatments

[Research Material] Global Market for Mucopolysaccharidosis Treatments

World Market for Mucopolysaccharidosis Treatments: Intravenous Injection, Intracerebroventricular (ICV), Hospitals, Clinics, Others

This research report (Global Mucopolysaccharidosis Therapeutics Market) investigates and analyzes the current status and outlook for the global market for mucopolysaccharidosis therapeutics over the next five years. It includes information on the overview of the global mucopolysaccharidosis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on intravenous injection and intracerebroventricular (ICV) administration, while the segments by application target hospitals, clinics, and others. The regional segments calculate the market size for mucopolysaccharidosis therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in mucopolysaccharidosis therapeutics, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Troprostenil Therapeutics

[Research Material] Global Market for Troprostenil Therapeutics

World Market for Treprostinil Therapeutics: Remodulin, Tyvaso, Orenitram, Hospitals, Clinics

This research report (Global Treprostinil Drugs Market) investigates and analyzes the current state and outlook for the global market of treprostinil therapeutic drugs over the next five years. It includes information on the overview of the global treprostinil therapeutic drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Remodulin, Tyvaso, and Orenitram, while the segments by application focus on hospitals and clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of treprostinil therapeutic drugs. It also includes the market share of major companies in the treprostinil therapeutic drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Chronic Fatigue Syndrome Treatment

[Research Material] The Global Market for Chronic Fatigue Syndrome Treatment

Global Market for Chronic Fatigue Syndrome Treatment: Immune Boosters, Antivirals, Sleep Enhancers, CNS (Central Nervous System) Stimulants, Hospitals, Clinics, Research Institutions

This research report (Global Chronic Fatigue Syndrome Treatment Market) investigates and analyzes the current state of the global market for chronic fatigue syndrome treatment and its outlook for the next five years. It includes information on the overview of the global chronic fatigue syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the chronic fatigue syndrome treatment market focus on immunostimulants and antivirals, sleep enhancers, and CNS (central nervous system) stimulants, while the segments by application target hospitals, clinics, and research institutions. The regional segments calculate the market size for chronic fatigue syndrome treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. The report also includes the market share of major companies in chronic fatigue syndrome treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Point-of-Care Diagnostic Tests

[Market Report] Global Market for Point-of-Care Diagnostic Tests

With the rapid increase in demand for swift and accurate testing, the global market for POC (point-of-care) diagnostic tests is experiencing rapid growth.

The global POC market is experiencing unprecedented growth due to the increasing demand for rapid and accurate testing solutions. Point-of-care diagnostic tests, also known as bedside testing or near-patient testing, enable timely decision-making by healthcare professionals and improve patient outcomes through rapid diagnosis and treatment. As the value of rapid and accurate testing is recognized by healthcare institutions worldwide in enhancing patient care and streamlining healthcare delivery, the global POC market is poised for continued growth. Please check the application method from the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Organ Transplant Rejection Treatment Drug Market

[Market Report] Global Organ Transplant Rejection Treatment Drug Market

The global market for organ transplant rejection treatment drugs is rapidly expanding and is expected to reach 7 billion USD by 2031.

The global organ transplant rejection treatment drug market recorded a market size of 4.9 billion USD in 2022 and is expected to see significant expansion. It is projected to grow at a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2023 to 2031, reaching an estimated value of 7 billion USD by 2031. The driving forces behind this growth are the increase in organ transplant surgeries and advancements in immunosuppressive therapies. The growth of the global organ transplant rejection treatment drug market plays a crucial role in enhancing the quality of life for transplant recipients. Continuous technological innovations and advancements will make this market extremely important in ensuring the success of organ transplant surgeries worldwide. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Neuropathic Pain Medications

[Market Report] Global Market for Neuropathic Pain Medications

The global market for neuropathic pain treatment drugs is expected to rapidly expand to $10.4 billion by 2031, alleviating suffering worldwide.

The global market for neuropathic pain medications is specialized in improving the lives of people suffering from neuropathic pain and has made significant progress. In 2022, this important market generated approximately $5.8 billion in revenue. It is projected to reach an estimated $10.4 billion by 2031, showing a stable compound annual growth rate (CAGR) of 5% during the forecast period from 2023 to 2031. Neuropathic pain is characterized by sharp, stabbing pain and burning sensations, often caused by nerve damage or dysfunction. Neuropathic pain is a complex condition that significantly impacts the quality of life for millions of people worldwide. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Psoriasis Treatments

[Market Report] Global Market for Psoriasis Treatments

The global market for psoriasis treatments is expected to rapidly expand, reaching 55.72 billion USD by 2031.

The global market for psoriasis treatments has experienced significant growth and plays a crucial role in addressing this challenging skin condition. In 2022, the market size reached 25.2 billion USD and is projected to reach 55.72 billion USD by 2031. This notable increase indicates a steady compound annual growth rate (CAGR) of 9.3% during the forecast period from 2023 to 2031. Psoriasis is a chronic skin disease affecting millions of people worldwide, characterized by red, itchy, scaly patches on the skin's surface. The increasing prevalence of psoriasis, heightened awareness, and advancements in treatment options are driving the expansion of the psoriasis treatment market. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Pulmonary Arterial Hypertension

[Market Report] Global Market for Pulmonary Arterial Hypertension

The global market for pulmonary arterial hypertension is projected to reach 10.8 billion dollars by 2031.

The global pulmonary arterial hypertension (PAH) market reached a revenue of $7 billion in 2022 and is aiming for significant growth. Projections indicate that the market will reach $10.8 billion by 2031, with a compound annual growth rate (CAGR) of 5% from 2023 to 2031. This growth reflects the increasing demand for effective treatments for this serious and life-threatening disease. Pulmonary arterial hypertension is a rare but severe condition characterized by high blood pressure in the lungs. It involves narrowing or blockage of the pulmonary arteries and capillaries, leading to increased strain on the heart and gradually worsening symptoms. Without timely and effective treatment, PAH can be life-threatening, highlighting the urgent need for advanced treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Diabetic Nephropathy Market

[Market Report] Global Diabetic Nephropathy Market

The global diabetic nephropathy market is advancing in the fight against kidney disease, expected to reach 3.37 billion USD by 2031.

The global diabetic nephropathy market is at the forefront of combating kidney disorders in diabetic patients, offering hope and advanced treatment options. According to recent market reports, the global diabetic nephropathy market generated approximately $2 billion in revenue in 2022 and is estimated to surge to about $3.37 billion by 2031. This noteworthy growth trajectory is driven by a solid annual compound growth rate (CAGR) of 6% projected from 2023 to 2031. Diabetic nephropathy, a long-term kidney disorder, is a significant concern for those living with diabetes. This condition occurs when persistently elevated blood sugar levels cause damage to kidney function. Diabetic nephropathy can affect patients with type 2 diabetes and is primarily characterized by damage to the smallest blood vessels in the kidneys. When these small blood vessels are damaged, proteins begin to leak into the urine from both kidneys, indicating renal dysfunction. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Nucleic Acid Medicine Market

[Market Report] Global Nucleic Acid Medicine Market

Global Nucleic Acid Drug Market: Expected to Reach 12 Billion USD by 2031 Due to Advances in Precision Medicine and Targeted Therapies.

The global nucleic acid therapeutics market is at the forefront of the pharmaceutical industry's push towards precision medicine and targeted therapies. According to recent market reports, the global nucleic acid therapeutics market is estimated to achieve approximately $4.5 billion in revenue by 2022 and surge to $12 billion by 2031. This remarkable growth trajectory is driven by powerful compounds. The compound annual growth rate (CAGR) is projected to be 11.6% from 2023 to 2031. Nucleic acid therapeutics encompass a wide range of innovative treatments, including ribonucleic acid (RNA) therapeutics and deoxyribonucleic acid (DNA) therapeutics. These therapies further include enzymes, antisense oligonucleotides, DNA aptamers, ribozymes, micro RNA, RNA decoys, and short interfering RNA, all designed to target disease-causing genes while preserving healthy cells and tissues. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] mRNA Vaccine and RNAi Therapeutics Market

[Market Report] mRNA Vaccine and RNAi Therapeutics Market

The global mRNA vaccine and RNAi therapeutic market is expected to achieve remarkable growth, reaching 10.783 billion US dollars by 2031.

The global market for mRNA vaccines and RNAi therapeutics is on a remarkable growth trajectory, with reported revenues reaching approximately $929.5 million in 2022. Forecasts suggest that this dynamic market is expected to achieve a substantial valuation of $10.783 billion by 2031, with an impressive compound annual growth rate (CAGR) of 31.3% during the forecast period from 2023 to 2031. Messenger ribonucleic acid (mRNA) serves as a crucial component of the genome and acts as a blueprint for protein synthesis within cells. mRNA vaccines and RNAi therapeutics encapsulate desirable immunological properties and are meticulously developed in laboratories using mammalian cells. Notable categories of vaccines and therapeutics include non-replicating mRNA, self-amplifying mRNA, in vivo self-replicating mRNA, and in vitro dendritic cell non-replicating mRNA. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Lyme Disease Treatment Market

[Market Report] Global Lyme Disease Treatment Market

The global Lyme disease treatment market is expected to achieve steady growth, reaching 1.652 billion USD by 2031.

The global Lyme disease treatment market is aiming for significant expansion, with revenues reaching approximately $799.4 million in 2022. Recent market analysis indicates that this sector is expected to experience a robust compound annual growth rate (CAGR) of 8.4% in 2022. The forecast period is from 2023 to 2031, with an estimated value of $1.652 billion by 2031. This increase is attributed to the rising global prevalence of Lyme disease and the development of innovative treatments. As the prevalence of Lyme disease continues to rise and research efforts focus on developing more effective treatment options, the global Lyme disease treatment market is poised for continuous growth. Increased investment in research and development, expanded access to healthcare, and heightened awareness of Lyme disease among healthcare professionals and the general public are expected to lead to significant advancements in the diagnosis and treatment of this debilitating disease. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global Market Size of Migraine Treatment Drugs

Global Market Size of Migraine Treatment Drugs

This report systematically organizes the medium- to long-term growth trends of the migraine treatment drug market through both quantitative and qualitative analyses.

This document provides an explanation of the global market size for migraine treatment drugs. It covers an overview of migraine treatment drugs, analysis by product type, analysis by application, analysis by company, analysis by region, technological innovations, and future market outlook. Our company, based in Tokyo, integrates industrial information from around the world and provides reports to support corporate decision-making. *For more details, please download the PDF or feel free to contact us.*

  • others
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Current Status of Pain Treatment: Medical Needs, Basic Research, and Exploration of New Therapeutics

Current Status of Pain Treatment: Medical Needs, Basic Research, and Exploration of New Therapeutics

★What are the actual drug selection and treatment processes for chronic pain management? ★Profile of the desired medication, expected cascade, and promising future analgesic cascades.

【Lecturers】 Professor Shinsuke Hamaguchi, Department of Anesthesiology, Dokkyo Medical University Dr. Kenji Miki, Deputy Chief of Orthopedics, Amagasaki Central Hospital, Specialist in Pain Management, Osaka University Medical Hospital 【Venue】Industrial Promotion Hall, Conference Room 1【Kanagawa, Kawasaki Station】 【Date and Time】December 13, 2010 (Monday) 11:00-15:00 【Capacity】30 people *Registration will close once full. Please apply early. 【Participation Fee】45,150 yen per person (including tax, textbook fee, and tea cost) New members applying for the first time by December 3 will receive an early bird discount price of 39,900 yen. ◆For two applicants from the same organization, the fee is 69,300 yen. For more details or to consider applying, please use the URL below ▼ http://ec.techzone.jp/products/detail.php?product_id=1270

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Key Points of Global Quality Assurance System and Safety Assurance in GMP for Investigational Drugs

Key Points of Global Quality Assurance System and Safety Assurance in GMP for Investigational Drugs

★A thorough explanation from the basics to global compliance measures for clinical trial drug GMP, taking into account audit experience! ★Introducing many actual concrete examples, including responses to QP!

【Instructor】QA Advisor, Doctor of Medicine, Akira Nomura 【Venue】Kawasaki City Educational and Cultural Center, Room 1 　【Kanagawa, Kawasaki】10 minutes on foot from JR and Keikyu "Kawasaki Station," 12 minutes from JR Shinagawa Station to Kawasaki Station 【Date and Time】January 26, 2011 (Wednesday) 13:00-16:30 【Capacity】30 people 【Attendance Fee】45,150 yen per person (including tax and text costs)

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Tateyama Chemical Co., Ltd. Quality Assurance System

Tateyama Chemical Co., Ltd. Quality Assurance System

With "creative practice" as a keyword, we are constantly reevaluating our quality assurance system.

Our company started with the production of methyl ephedrine, an active pharmaceutical ingredient (API) for expectorants. The manufacturing of APIs and their quality control are the very roots of Tateyama Chemical. Aiming for world-class quality assurance, we achieve global-level quality assurance that complies not only with Japan's GMP, which is the standard for pharmaceutical manufacturing and quality control, but also with PIC/S GMP, to supply safe, effective, and high-quality pharmaceuticals to countries around the world. To respond to the trust of various customers and ultimately the end users, we will continuously update our quality control system. 【Management Policy】 ■ Development of new products ■ Refinement of technology ■ Thorough implementation of 5S and quality control ■ Raising awareness of environmental conservation and health and safety *For more details, please refer to the PDF materials or feel free to contact us.

  • Contract manufacturing
  • Chemicals
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Aptamer drug discovery technology

Aptamer drug discovery technology

Created using the SELEX method (in vitro artificial evolution method)! It is possible to develop various new drugs.

We would like to introduce our "Aptamer Drug Discovery Technology." Our core drug discovery technology, the "RiboART System," is built on comprehensive technologies, knowledge, and experience related to aptamer drug discovery, creating a platform (drug discovery foundation) that can be widely applied to the generation of new drug candidates. By using this system, it is possible to create various new drugs that are not limited to specific diseases or target proteins. 【Flow】 ■ SELEX method ■ Binding property measurement ■ Shortening, re-SELEX, chemical modification ■ Cell testing ■ Animal testing ■ Toxicity testing *For more details, please refer to the PDF document or feel free to contact us.

  • Other Protein Research
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[CPhI Seminar Report] Mutagenic Impurities in Pharmaceuticals (Active Pharmaceutical Ingredients)

[CPhI Seminar Report] Mutagenic Impurities in Pharmaceuticals (Active Pharmaceutical Ingredients)

Development of testing methods and analysis examples! Established over 300 analytical methods that can guarantee PMI residues below 10 ppm!

At "CPhI Japan 2022," we held a presentation in our booth regarding ICH M7 compliance from the Development and Analytical Research Headquarters. We introduced the day's content, including "About ICH M7," "For the Development of Trace Analysis Methods," and "Examples of Method Validation." Please take a moment to read it. [Contents] ■ About ICH M7 ■ For the Development of Trace Analysis Methods ■ Examples of Method Validation ■ Conclusion *For more details, please refer to the related links page or feel free to contact us.

  • Other Testing Contract
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Document] Global Market for Composite Calamine Lotion

[Research Document] Global Market for Composite Calamine Lotion

Global Market for Compound Calamine Lotion: 50ml, 100ml, Urticaria, Eczema, Others

This research report (Global Compound Calamine Lotion Market) investigates and analyzes the current status and outlook for the global market of compound calamine lotion over the next five years. It includes information on the overview of the global compound calamine lotion market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on 50ml and 100ml, while the segments by application target urticaria, eczema, and others. The regional segments calculate the market size of compound calamine lotion by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the compound calamine lotion sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Nosebleed Treatment Drugs

[Research Material] Global Market for Nosebleed Treatment Drugs

Global Market for Nosebleed Treatments: Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents, Septal Deviation, Intranasal Inflammation, Others

This research report (Global Epistaxis Therapeutics Market) investigates and analyzes the current state and outlook for the global market for epistaxis therapeutics over the next five years. It includes information on the global epistaxis therapeutics market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the epistaxis therapeutics market include vasoconstrictors, anesthetics, antibiotic ointments, and cauterizing agents, while the segments by application focus on septal deviation, nasal inflammation, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for epistaxis therapeutics. It also includes the market share of major companies in epistaxis therapeutics, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Angina Treatment Drugs

[Research Material] Global Market for Angina Treatment Drugs

Global Market for Angina Treatment Drugs: Beta Blockers, Calcium Channel Blockers, Anticoagulants, Antiplatelet Agents, Others, Hospitals, Clinics, ASC

This research report (Global Angina Pectoris Drugs Market) investigates and analyzes the current status and outlook for the global market of angina treatment drugs over the next five years. It includes information on the overview of the global angina treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include beta-blockers, calcium channel blockers, anticoagulants, antiplatelet agents, and others, while the segments by application focus on hospitals, clinics, and ASCs. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for angina treatment drugs. It also includes the market share of major companies in the angina treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Document] Global Market for Fluticasone Propionate & Salmeterol

[Research Document] Global Market for Fluticasone Propionate & Salmeterol

World Market for Fluticasone Propionate & Salmeterol: Inhalation Powder, Inhalation Aerosol, Asthma, COPD

This research report (Global Fluticasone Propionate and Salmeterol Market) investigates and analyzes the current status and outlook for the global market of fluticasone propionate and salmeterol over the next five years. It includes information on the overview of the global fluticasone propionate and salmeterol market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for fluticasone propionate and salmeterol focus on inhalation powder and inhalation aerosol, while the segments by application target asthma and COPD. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for fluticasone propionate and salmeterol. It also includes the market share of major companies in fluticasone propionate and salmeterol, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Neutropenia Treatment Drugs

[Research Material] Global Market for Neutropenia Treatment Drugs

World Market for Treatment of Neutropenia: Capsules, Injections, Hospitals, Clinics

This research report (Global Neutropenia Drugs Market) investigates and analyzes the current state and future outlook of the global market for neutropenia treatment drugs over the next five years. It includes information on the overview of the global neutropenia treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include capsules and injections, while the segments by application focus on hospitals and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for neutropenia treatment drugs accordingly. It also includes the market share of major companies in the neutropenia treatment drugs sector, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for CARASIL Treatment

[Research Material] The Global Market for CARASIL Treatment

Global Market for CARASIL Treatment: Vesicular Monoamine Transporter 2 Inhibitors, Selective Serotonin Reuptake Inhibitors (SSRIs), Cholinergic/...

This research report (Global Carasil Treatment Market) investigates and analyzes the current status and outlook for the global CARASIL treatment market over the next five years. It includes information on the overview of the global CARASIL treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the CARASIL treatment market include vesicular monoamine transporter 2 inhibitors, selective serotonin reuptake inhibitors (SSRIs), cholinergic/cholinesterase (Che) inhibitors, atypical antipsychotics, combination drugs (donepezil and memantine), MAO inhibitors, and glutamate inhibitors. The segments by application target hospitals, clinics, drugstores, and online pharmacies. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for CARASIL treatment. The report also includes the market share of major companies in CARASIL treatment, product and business overviews, and sales performance.

  • Other services
  • medicine

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

IPROS Services
COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.